Kenneth W. O'Keefe - 05 Aug 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kenneth W O'Keefe
Issuer symbol
JAZZ
Transactions as of
05 Aug 2022
Net transactions value
-$165,883
Form type
4
Filing time
09 Aug 2022, 18:34:52 UTC
Previous filing
10 Aug 2021
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +2,561 +13% $0.000000 22,168 05 Aug 2022 Direct F1
transaction JAZZ Ordinary Shares Sale $165,883 -1,089 -4.9% $152.33 21,079 08 Aug 2022 Direct F2
holding JAZZ Ordinary Shares 4,445 05 Aug 2022 by Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023.
F2 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F3 Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.